Literature DB >> 5031613

Antibody to mycobacterial antigens in adjuvant arthritis (AA). I. Relationship to disease and delayed hypersensitivity.

R J Perper, A L Oronsky, V Blancuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5031613     DOI： 10.1002/art.1780150310

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Suppression of rat adjuvant disease by cyclophosphamide pretreatment: evidence for an antibody mediated component in the pathogenesis of the disease.

Authors:  A R Mackenzie; C R Pick; P R Sibley; B P White
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

2.  Influence of tubercle aggregate size on severity of adjuvant arthritis in the rat.

Authors:  S P Liyanage; H L Currey; B Vernon-Roberts
Journal:  Ann Rheum Dis       Date:  1975-02       Impact factor: 19.103

3.  An unusual profile of activity of a new basic anti-inflammatory drug, timegadine.

Authors:  E Bramm; L Binderup; E Arrigoni-Martelli
Journal:  Agents Actions       Date:  1981-07

4.  Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis.

Authors:  P Hambleton; S McMahon
Journal:  Agents Actions       Date:  1990-03

5.  The absence of antibodies to type II collagen in established adjuvant arthritis in rats.

Authors:  F DeLustro; R P Carlson; L J Datko; B DeLustro; A J Lewis
Journal:  Agents Actions       Date:  1984-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.